Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Lyman

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Cancer Investigation|March 4, 2025
Artificial Intelligence in Cancer Clinical Research: V. What We Have Learned About Human Intelligence from Artificial IntelligenceGary Lyman, Nicole Kuderer
American Clinical Laboratory|May 8, 2002
Hepatitis B virus vaccine: cost effects and insurance coverageRama Ganguly, Gary Lyman, Brandon Lenox
Current Medical Research and Opinion|February 6, 2009
Cost-effectiveness of pegfilgrastim versus 6-day filgrastim primary prophylaxis in patients with non-Hodgkin's lymphoma receiving CHOP-21 in United StatesGary Lyman, Anjana Lalla, Richard Barron, et al.
Cancer Treatment Reviews|March 14, 2003
Evidence-based oncology in cancer treatment reviewsBenjamin Djulbegovic, Robert Coleman, Rolf Stahel, et al.
Chemotherapy|February 21, 2012
Risk and healthcare costs of chemotherapy-induced neutropenic complications in women with metastatic breast cancerDerek Weycker, John Edelsberg, Alex Kartashov, et al.
Current Medical Research and Opinion|August 19, 2007
Comparison of pegfilgrastim with filgrastim on febrile neutropenia, grade IV neutropenia and bone pain: a meta-analysis of randomized controlled trialsLionel Pinto, Zhimei Liu, Quan Doan, et al.
Nature Cancer|April 30, 2020
Crowdsourcing a crisis response for COVID-19 in oncologyAakash Desai, Jeremy Warner, Nicole Kuderer, et al.
Nature Cancer|February 5, 2022
Crowdsourcing a crisis response for COVID-19 in oncologyAakash Desai, Jeremy Warner, Nicole Kuderer, et al.
Human Pathology|January 12, 2008
Lack of expression of androgen receptor may play a critical role in transformation from in situ to invasive basal subtype of high-grade ductal carcinoma of the breastKrisztina Hanley, Jianmin Wang, Patricia Bourne, et al.
Journal of Managed Care & Specialty Pharmacy|January 27, 2023
Risk of chemotherapy-induced febrile neutropenia in intermediate-risk regimens: Clinical and economic outcomes of granulocyte colony-stimulating factor prophylaxisSaad Aslam, Edward Li, Elizabeth Bell, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Cancer Investigation|March 4, 2025
Artificial Intelligence in Cancer Clinical Research: V. What We Have Learned About Human Intelligence from Artificial IntelligenceGary Lyman, Nicole Kuderer
American Clinical Laboratory|May 8, 2002
Hepatitis B virus vaccine: cost effects and insurance coverageRama Ganguly, Gary Lyman, Brandon Lenox
Current Medical Research and Opinion|February 6, 2009
Cost-effectiveness of pegfilgrastim versus 6-day filgrastim primary prophylaxis in patients with non-Hodgkin's lymphoma receiving CHOP-21 in United StatesGary Lyman, Anjana Lalla, Richard Barron, et al.
Cancer Treatment Reviews|March 14, 2003
Evidence-based oncology in cancer treatment reviewsBenjamin Djulbegovic, Robert Coleman, Rolf Stahel, et al.
Chemotherapy|February 21, 2012
Risk and healthcare costs of chemotherapy-induced neutropenic complications in women with metastatic breast cancerDerek Weycker, John Edelsberg, Alex Kartashov, et al.
Current Medical Research and Opinion|August 19, 2007
Comparison of pegfilgrastim with filgrastim on febrile neutropenia, grade IV neutropenia and bone pain: a meta-analysis of randomized controlled trialsLionel Pinto, Zhimei Liu, Quan Doan, et al.
Nature Cancer|April 30, 2020
Crowdsourcing a crisis response for COVID-19 in oncologyAakash Desai, Jeremy Warner, Nicole Kuderer, et al.
Nature Cancer|February 5, 2022
Crowdsourcing a crisis response for COVID-19 in oncologyAakash Desai, Jeremy Warner, Nicole Kuderer, et al.
Human Pathology|January 12, 2008
Lack of expression of androgen receptor may play a critical role in transformation from in situ to invasive basal subtype of high-grade ductal carcinoma of the breastKrisztina Hanley, Jianmin Wang, Patricia Bourne, et al.
Journal of Managed Care & Specialty Pharmacy|January 27, 2023
Risk of chemotherapy-induced febrile neutropenia in intermediate-risk regimens: Clinical and economic outcomes of granulocyte colony-stimulating factor prophylaxisSaad Aslam, Edward Li, Elizabeth Bell, et al.
Pageof 2